Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
we are missing the change in eGFR within the <60 eGFR cohort of the BETonMACE study. Specifically, the relative change between those receiving standard of care/placebo and those receiving apabetalone. No change??? maybe, but unlikely in my uneducated humble opinion. How else would one explain a 50% RRR of MACE for those receiving apabetalone versus those on standard of care/placebo
